Text Size

Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier:
NCT00500695
First received: July 12, 2007
Last updated: July 19, 2012
Last verified: July 2012
History of Changes
  Purpose

This project will assess the utility of a brief motivational intervention to engage smokers with schizophrenia in treatment for tobacco dependence treatment. It is hypothesized that a brief motivational intervention will be more effective in engaging smokers with schizophrenia to tobacco dependence treatment than an educational intervention. The educational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by teaching subjects about the negative effects of smoking and the success of tobacco dependence treatment. The motivational intervention will increase the likelihood to reducing cigarette intake and/or attending tobacco dependence treatment by increasing subjects' motivation to change by presenting objective and personalized information regarding their smoking behaviors in a non-judgmental and supportive manner.


Condition Intervention Phase
Schizophrenia
Schizoaffective Disorder
 Behavioral: Motivational Interviewing or Psychoeducational Intervention
 Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Medicine and Dentistry New Jersey:

Primary Outcome Measures:
  • Attendance at first smoking cessation session [ Time Frame: one month ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cigarettes per day [ Time Frame: 1-Month Follow Up ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: May 2006
Estimated Study Completion Date: October 2013
Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Counseling Behavioral: Motivational Interviewing or Psychoeducational Intervention
one-session, 45-minute behavioral intervention

Detailed Description:

See Brief Summary above.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Current smokers must be over the age of 18,
  • Must have a diagnosis of schizophrenia or schizoaffective disorder
  • Must smoke at least 10 cigarettes per day
  • Must be capable of giving informed consent as measured by Folstein Mini Mental Status Exam of at least 22

Exclusion Criteria:

•Those unable to give informed consent.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00500695

Locations
United States, New Jersey
UMDNJ- Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901
Sponsors and Collaborators
University of Medicine and Dentistry New Jersey
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Marc L. Steinberg, PH.D. University of Medicine and Dentistry New Jersey
  More Information

No publications provided

Responsible Party: University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier: NCT00500695     History of Changes
Other Study ID Numbers: K23DA018203, K23DA018203
Study First Received: July 12, 2007
Last Updated: July 19, 2012
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Schizophrenia
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on June 13, 2013